MoreBetter Announces Statewide Medical Cannabis Registry in Mississippi
MMJDaily reports MoreBetter is rolling out a Mississippi registry, but pricing, scope and state sign-off remain undisclosed as of Nov. 11.

Stunning aerial view of the iconic California State Capitol in Sacramento surrounded by cityscape.
What MoreBetter said, and what's missing
MoreBetter is rolling out a statewide medical cannabis registry in Mississippi, according to a Nov. 11 MMJDaily report, but the public record on its terms is thin.
The signal CannIntel reviewed is a headline and a publication stamp. It has no financial terms, no ticker, no filing and no named state official.
That matters. A registry can mean several different things: a patient-facing directory, a provider referral database, a compliance tool for dispensaries, or a data layer sitting beside the state's own card system. Each carries a different business model.
Here's what we couldn't confirm:
- Whether the Mississippi State Department of Health (MSDH) is a partner, a customer or neither
- Whether enrollment is voluntary or tied to patient card issuance
- Who pays: patients, practitioners, licensed businesses or investors
- How patient data would be stored, shared and protected
We'll update this story when MoreBetter or MMJDaily supplies the details.
Where Mississippi's program already stands
Mississippi already runs a state-regulated medical program, so any private registry has to fit inside a framework the Legislature wrote in 2022.
Voters approved Initiative 65 in November 2020. The Mississippi Supreme Court struck down the ballot measure in May 2021 on procedural grounds, wiping out the voter-written program.
The Legislature then passed the Mississippi Medical Cannabis Act, which Gov. Tate Reeves signed in early 2022. Under that law, MSDH handles patient and practitioner administration, and the Mississippi Department of Revenue licenses and oversees cannabis businesses.
So the state already has an official channel for patient cards, and a third-party registry is either additive, a layer on top, or competitive. Everything hangs on which one it is.
The open question isn't whether Mississippi needs better patient and product data. It's who owns that data once it exists.
The operator and investor read
With no financial terms disclosed, the registry is a distribution story, not an earnings story, and operators should treat it that way until they see a fee schedule.
Markets reporters look for the numbers first: revenue per enrolled patient, take rates, contract length, any basis-point cut on transactions. None of it's in the signal. We found no filing tied to the announcement.
No ticker either. That alone tells you something about the stakes for public-market investors: for now, they're limited.
For licensed dispensaries and cultivators in Mississippi, the practical questions are narrower:
- Integration cost. Does the registry plug into existing point-of-sale and seed-to-sale systems, or add a parallel workflow?
- Compliance exposure. If the registry holds patient status, who answers to regulators when it's wrong?
- Exclusivity. Does participation lock a business into one vendor?
A statewide label is easy to say and hard to deliver. It takes state cooperation, or it takes a lot of voluntary sign-ups. A registry nobody is required to use is just a database.
The patient lens, and what to watch
For patients, the test is simple: does the registry reduce friction without creating a new place where sensitive health data can leak.
Medical cannabis registries hold some of the most sensitive information a state or vendor can collect, because they tie a diagnosis to a legally gray product under federal law. Patients enrolled in a private system should know whether it's covered by the same protections as a state health agency record. That's a fair thing to ask before anyone signs up.
It's hard to argue with that. If a private registry can't answer data-governance questions on day one, patients and practitioners have little reason to adopt it.
For full background on how the state's rules, licensing and patient access fit together, see the CannIntel topic hub on the Mississippi Medical Cannabis Program.
The next signal: a statement from MSDH or the Department of Revenue on whether it recognizes, partners with or is unaffected by the MoreBetter registry, plus a published fee and data-handling policy from the company.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Medical

Oregon health officials update review of cannabis health effects
State health officials refreshed their review of cannabis health effects, weighing risks against benefits, according to NPR for Oregonians coverage published Nov. 11.

Dragonfly Wellness' Panh Says Veterans Need Access, Not Discounts
A Veterans Day op-ed argues that dispensary discounts mask the real barrier: veterans still struggle to access medical cannabis through the system meant to serve them.

CSIR-IIIM Cannabis Research Project Advances Toward Pre-Clinical Trials
India's Jammu-based CSIR-IIIM moved its medicinal cannabis project closer to pre-clinical testing, MMJDaily reported, but the compounds, indications and timeline remain unpublished.
More from the newsroom

Vicente LLP Sets Webinar on DEA Registration Denials for Cannabis
The law firm's session targets operators weighing next steps after DEA registration denials and questions over whether applicants complied on time, a gap the signal does not fully detail.

Texas Lt. Gov.-elect Goodwin Puts Marijuana on 2027 Agenda
Vikki Goodwin, Texas's lieutenant governor-elect, listed marijuana alongside education, gambling and Medicaid as priorities ahead of the 2027 legislative session, according to KSAT.

Newswire Item Says DEA Restricts State Medical Marijuana Operators
A Nov. 11 headline describes DEA action against state medical programs, but names no state, rule or docket, so the claim awaits a primary document.